Poseida’s Solid Tumor CAR-T Shows Early Promise, But Safety Will Be Closely Watched
Promising Signs In Prostate Cancer
Developing CAR-Ts against solid tumors that are both safe and effective is proving a huge technical challenge, but San Diego biotech Poseida believes it has made important progress.
